Malcolm A. King

870 total citations
21 papers, 755 citations indexed

About

Malcolm A. King is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Malcolm A. King has authored 21 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Malcolm A. King's work include Cell death mechanisms and regulation (7 papers), Phagocytosis and Immune Regulation (4 papers) and DNA Repair Mechanisms (3 papers). Malcolm A. King is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Phagocytosis and Immune Regulation (4 papers) and DNA Repair Mechanisms (3 papers). Malcolm A. King collaborates with scholars based in Australia, United States and Japan. Malcolm A. King's co-authors include Robert C. Baxter, Alison J. Butt, Sue M. Firth, Zbigniew Darżynkiewicz, Xuan Huang, Frank Traganos, H. Dorota Halicka, Wei Dai, Masaki Okafuji and Stella McGinn and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and American Journal of Physiology-Cell Physiology.

In The Last Decade

Malcolm A. King

21 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm A. King Australia 15 468 148 147 119 90 21 755
Xinjun Wang China 19 486 1.0× 109 0.7× 163 1.1× 51 0.4× 98 1.1× 57 879
Pavel Spirin Russia 18 644 1.4× 109 0.7× 142 1.0× 60 0.5× 67 0.7× 90 1.0k
Katarzyna Marta Lisowska Poland 16 736 1.6× 295 2.0× 338 2.3× 85 0.7× 147 1.6× 36 1.3k
Rick V. Hay United States 18 960 2.1× 157 1.1× 132 0.9× 64 0.5× 75 0.8× 28 1.4k
Shilpi Rajoria United States 12 377 0.8× 140 0.9× 95 0.6× 180 1.5× 115 1.3× 21 730
Joan Riley United Kingdom 16 620 1.3× 199 1.3× 196 1.3× 19 0.2× 69 0.8× 44 1.0k
Valentina K. Todorova United States 16 230 0.5× 142 1.0× 148 1.0× 11 0.1× 52 0.6× 30 631
Steven Hayes United States 11 423 0.9× 146 1.0× 84 0.6× 63 0.5× 46 0.5× 12 749
Jalal A. Jazayeri Australia 15 471 1.0× 163 1.1× 75 0.5× 21 0.2× 104 1.2× 24 779
Jianfu Zhou China 15 491 1.0× 161 1.1× 103 0.7× 16 0.1× 157 1.7× 29 794

Countries citing papers authored by Malcolm A. King

Since Specialization
Citations

This map shows the geographic impact of Malcolm A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm A. King more than expected).

Fields of papers citing papers by Malcolm A. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm A. King. The network helps show where Malcolm A. King may publish in the future.

Co-authorship network of co-authors of Malcolm A. King

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm A. King. A scholar is included among the top collaborators of Malcolm A. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm A. King. Malcolm A. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terrazzino, Salvatore, et al.. (2017). P1.03-014 Saline Alone vs Saline plus Mannitol Hydration for the Prevention of Acute Cisplatin Nephrotoxicity: A Randomized Trial. Journal of Thoracic Oncology. 12(11). S1956–S1956. 1 indexed citations
2.
King, Malcolm A., Ayad Eddaoudi, & Derek Davies. (2007). A comparison of three flow cytometry methods for evaluating mitochondrial damage during staurosporine‐induced apoptosis in Jurkat cells. Cytometry Part A. 71A(9). 668–674. 14 indexed citations
4.
King, Malcolm A., Dorota Halicka, & Zbigniew Darżynkiewicz. (2004). Pro- and Anti-Apoptotic Effects of an Inhibitor of Chymotrypsin-Like Serine Proteases. Cell Cycle. 3(12). 1566–1571. 17 indexed citations
5.
Darżynkiewicz, Zbigniew, Xuan Huang, Masaki Okafuji, & Malcolm A. King. (2004). Cytometric Methods to Detect Apoptosis. Methods in cell biology. 75. 307–341. 47 indexed citations
6.
Huang, Xuan, Malcolm A. King, H. Dorota Halicka, et al.. (2004). Histone H2AX phosphorylation induced by selective photolysis of BrdU‐labeled DNA with UV light: Relation to cell cycle phase. Cytometry Part A. 62A(1). 1–7. 16 indexed citations
7.
Halicka, H. Dorota, Xuan Huang, Frank Traganos, et al.. (2004). Histone H2AX Phosphorylation after Cell Irradiation with UV-B: Relationship to Cell Cycle Phase and Induction of Apoptosis. Cell Cycle. 4(2). 338–344. 113 indexed citations
8.
King, Malcolm A., et al.. (2002). Antimycin A‐induced apoptosis of HL‐60 cells. Cytometry. 49(3). 106–112. 31 indexed citations
9.
King, Malcolm A., et al.. (2002). Effects of caspase inhibition on camptothecin‐induced apoptosis of HL‐60 cells. Cytometry. 49(1). 28–35. 15 indexed citations
11.
King, Malcolm A.. (2000). Detection of dead cells and measurement of cell killing by flow cytometry. Journal of Immunological Methods. 243(1-2). 155–166. 101 indexed citations
12.
Butt, Alison J., Sue M. Firth, Malcolm A. King, & Robert C. Baxter. (2000). Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells. Journal of Biological Chemistry. 275(50). 39174–39181. 192 indexed citations
15.
King, Malcolm A., Gregory R. Donovan, Dianne Alewood, et al.. (1998). Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula. Biochimica et Biophysica Acta (BBA) - General Subjects. 1425(1). 74–80. 31 indexed citations
16.
King, Malcolm A., et al.. (1998). Flow cytometric analysis of cell killing by the jumper ant venom peptide pilosulin 1. Cytometry. 32(4). 268–273. 13 indexed citations
18.
King, Malcolm A., et al.. (1996). Natural killer cells and CD56+ T cells in the blood of multiple myeloma patients: Analysis by 4-colour flow cytometry. Cytometry. 26(2). 121–124. 23 indexed citations
19.
King, Malcolm A., et al.. (1992). Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: how prevalent is light chain isotype suppression?. British Journal of Haematology. 81(2). 218–222. 5 indexed citations
20.
Norris, Murray D., Michelle Haber, Malcolm A. King, & Ross Davey. (1989). Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: Reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression. Biochemical and Biophysical Research Communications. 165(3). 1435–1441. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026